BE836156A - Vaccin contre les oreillons et son procede de preparation - Google Patents

Vaccin contre les oreillons et son procede de preparation

Info

Publication number
BE836156A
BE836156A BE162343A BE162343A BE836156A BE 836156 A BE836156 A BE 836156A BE 162343 A BE162343 A BE 162343A BE 162343 A BE162343 A BE 162343A BE 836156 A BE836156 A BE 836156A
Authority
BE
Belgium
Prior art keywords
preparation
mumps vaccine
mumps
vaccine
Prior art date
Application number
BE162343A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE836156A publication Critical patent/BE836156A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165Mumps or measles virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE162343A 1974-12-02 1975-12-01 Vaccin contre les oreillons et son procede de preparation BE836156A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/528,752 US3961046A (en) 1974-12-02 1974-12-02 Mumps vaccine and preparation thereof

Publications (1)

Publication Number Publication Date
BE836156A true BE836156A (fr) 1976-06-01

Family

ID=24107030

Family Applications (1)

Application Number Title Priority Date Filing Date
BE162343A BE836156A (fr) 1974-12-02 1975-12-01 Vaccin contre les oreillons et son procede de preparation

Country Status (6)

Country Link
US (1) US3961046A (fr)
BE (1) BE836156A (fr)
CA (1) CA1059908A (fr)
DE (1) DE2553998C2 (fr)
FR (1) FR2293218A1 (fr)
NL (1) NL184196C (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55147227A (en) * 1979-05-04 1980-11-17 Handai Biseibutsubiyou Kenkyukai Preparrtion of attenuated live mumps vaccine
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
ES2000034A6 (es) * 1985-11-26 1987-10-01 Schweiz Serum & Impfinst Procedimiento para la preparacion de una vacuna viva contra paperas
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
AU7161591A (en) * 1989-12-29 1991-07-24 Symex Corp. Stable formulation of viral neuraminidase
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
WO1993024616A1 (fr) * 1992-06-04 1993-12-09 Merck & Co., Inc. Procede de production d'un vaccin attenue contre l'herpesvirus varicellae
US5728386A (en) * 1993-12-21 1998-03-17 Merck & Co., Inc. Thermostable varicella zoster virus
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
JPS528379B1 (fr) * 1971-04-30 1977-03-09

Also Published As

Publication number Publication date
FR2293218B1 (fr) 1979-09-21
NL7514014A (nl) 1976-06-04
US3961046A (en) 1976-06-01
DE2553998A1 (de) 1976-08-12
CA1059908A (fr) 1979-08-07
NL184196C (nl) 1989-05-16
FR2293218A1 (fr) 1976-07-02
NL184196B (nl) 1988-12-16
DE2553998C2 (de) 1986-11-06

Similar Documents

Publication Publication Date Title
FR2499412B1 (fr) Production de vaccin antivirus
FR2353641A1 (fr) Vaccin anti-tumoral et son procede de preparation
BG23212A3 (bg) Метод за получаване на арилоксифенилпропиламини
CS178889B2 (en) Method for preparation of oxazolopyridines and derivatives thereof
IT1059052B (it) Struttura e metodo per favorire la crescita di piante
IT1070714B (it) Metodo per la sterilizzazione di antere maschio
NL7502157A (nl) Piperidinederivaten en werkwijze voor de berei- ding daarvan.
FR2293218A1 (fr) Vaccin contre les oreillons et son procede de preparation
LU79508A1 (fr) Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation
FR2346022A1 (fr) Vaccin contre la rhinotracheite virale des felides et son procede de preparation
FR2291764A1 (fr) Diacylnucleosides et procede de preparation
BE853604A (fr) Vaccin antirabique et son procede de preparation
BE839306A (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
BE844353A (fr) Nouveau vaccin anti-rabique et son procede de preparation
CS191868B2 (en) Method of preparing live virus vaccine
AR214316A1 (es) Metodo de preparacion de fenetil-alquil-aminas terciarias
BE850696A (fr) Vaccin contre la panleucopenie des felides et son procede de preparation
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
BE831786A (fr) Vaccin contre la gravidite et procede de sa preparation
BE827157A (fr) Vaccin contre la rhinotracheite feline et sa production
BE808347A (fr) Composes heterocycliques et methode de preparation de ceux-ci
IT1027880B (it) Procedimento per la preparazione di pertilizzianti e di modificatori di terreni
FR2296627A1 (fr) 2-aryl-4-alcoxymethyl-5-methylimidazoles et procede de preparation
FR2331354A2 (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
FR2313942A1 (fr) Compositions antigeniques, leur procede de preparation et leur application comme vaccins

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: AMERICAN CYANAMID CY

Effective date: 19911231